Alpha Tau Medical Stock Today
| DRTSW Stock | USD 0.23 0.03 15.00% |
PerformanceInsignificant
| Odds Of DistressVery High
|
Alpha Tau is selling for under 0.23 as of the 21st of March 2025; that is 15.00 percent up since the beginning of the trading day. The stock's lowest day price was 0.2. Alpha Tau has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 8th of March 2021 | Category Healthcare | Classification Health Care |
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of solid cancer In Israel and the United States. The company was founded in 2015 and is headquartered in Jerusalem, Israel. More on Alpha Tau Medical
Moving together with Alpha Stock
Moving against Alpha Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Alpha Stock Highlights
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Medical Equipment, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Alpha Tau can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Alpha Tau's financial leverage. It provides some insight into what part of Alpha Tau's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Alpha Tau Medical (DRTSW) is traded on NASDAQ Exchange in USA. It is located in Kiryat Hamada Street 5, Jerusalem, Israel, 9777605 and employs 125 people. Alpha Tau is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry.
Alpha Tau generates negative cash flow from operations
Check Alpha Tau Probability Of Bankruptcy
Alpha Tau Historical Income Statement
Alpha Stock Against Markets
Alpha Tau Corporate Management
| Robert MD | Chief Board | Profile | |
| Rebecca Becker | Vice legal | Profile | |
| Pr Kelson | Chief Board | Profile | |
| Yael Zeiger | Corporate Controller | Profile | |
| Raphi Levy | Chief Officer | Profile | |
| Peter Melnyk | Chief Officer | Profile | |
| Pr Keisari | Chief board | Profile |
Additional Tools for Alpha Stock Analysis
When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.